Oren Shuster

Avant Brands Inc. (TSX: AVNT) (OTC-QX: AVTBF) (FRA: 1BU0) and IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) jointly announced on Wednesday the signing of an international trademark licensing agreement granting IMC the exclusive right to launch the BLKMKT brand in the Israeli medical cannabis market...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) is undertaking a non-brokered private placement for aggregate gross proceeds of up to $5 million. The offering, which is expected to close in one or more tranches, will be led by the company's management team, including Oren Shuster, CEO, and Marc...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released financial results for its second quarter ended June 30, 2022, revealing revenues increased 114% year-over-year to CA$23.8 million ($18.43 million). Q2 2022 Financial Results Gross profit was CA$4 million compared to a loss of CA$568,000 in Q2...

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a medical and adult-use cannabis company with operations in Israel, Canada, and Germany, announced its financial results on Thursday for the three months ended March 31, 2022 (Q1). Q1 2022 Financial Results Revenues were $23.6 million in Q1...

As the business of cannabis grows in size and opportunity, many companies in the space are wondering about the challenges of international expansion. Peter Simeon, partner at Gowling, asked this question of a panel of experts at the Benzinga Cannabis Capital Conference on April 20 at the...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released financial results for the three months and fiscal year ended December 31, 2021. Full Year 2021Financial Highlights Revenues in 2021 were CA$54.3 million ($43.38 million), representing an increase of 242% from 2020. Gross profit, before...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) has completed the strategic acquisition of 51% of the rights in Oranim Pharm partnership, a pharmacy selling medical cannabis in Israel. The acquisition was completed through IMC Holdings Ltd., a wholly-owned subsidiary of IM Cannabis Corp.,...

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) has completed three strategic acquisitions. The acquisitions were completed through IMC Holdings Ltd. a wholly-owned subsidiary of IM Cannabis Corp. and I.M.C Pharma Ltd., IMC Holdings' wholly-owned subsidiary, following receipt of all requisite...

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) has reported its preliminary unaudited financial results for the three months and fiscal year ended December 31, 2021. Preliminary Q4 & FY 2021 Financial Highlights Preliminary revenues were at least CA$20 million ($15.8 million) for the fourth...

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) announced on Wednesday that Focus Medical Herbs Ltd. has completed the importation of approximately 399 kilograms of premium indoor-grown Canadian dried cannabis from Trichome JWC Acquisition Corp., its wholly-owned Canadian cultivation subsidiary...

IM Cannabis Corp. (CSE: IMCC), (NASDAQ: IMCC) will acquire the majority of Jerusalem’s leading medical cannabis pharmacy, Oranim. The cannabis company confirmed Wednesday that its Israeli subsidiary IMC Holdings Ltd. will acquire 51.3% of the outstanding ordinary shares of Oranim Plus Pharm...

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC)  announced on Monday that it has received approval from the Israeli Ministry of Health to import premium, indoor-grown medical cannabis from Trichome JWC Acquisition Corp., its wholly-owned Canadian licensed producer that cultivates and sells the...

IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA$14.4 million ($11.5 million), a sequential increase of approximately 30%. The international cannabis company with...

Multi-country medical and recreational cannabis operator IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) reported its unaudited financial results on Monday for the three- and six-month periods ended June 30. The company, with operations in Israel, Germany and Canada, also announced it is...

Cannabidiol brand cbdMD, Inc. (NYSE: YCBD) has teamed up with IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) to enter the Israeli market. Based in Charlotte, North Carolina, cbdMD reported Monday it has inked a binding letter of intent with the multi-country company operating in Israel, Germany ...